97.
Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005;90:5226–5233.
98.
Davis SR, van der Mooren MJ, van Lunsen RHW, et al. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo controlled trial. Menopause 2006;13:387–396.
99.
Shifren JL, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 STUDY. Menopause 2006;13:770–779.
100.
Davis S, Moreau M, Kroll R, et al. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008;359:2005–2017.
101.
Panay N, Al-Azzawi F, Bouchard C, et al. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric 2010;13:121–131.
102.
Barton DL, Wender DB, Sloan JA, et al. Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido: North Central Cancer Treatment Group Protocol N02C3. J Nat Cancer Inst 2007;99:672–679.
103.
Davis S, Papalia MA, Norman RJ, et al. Safety and efficacy of a testosterone metered-dose transdermal spray for treatment of decreased sexual satisfaction in premenopausal women: a placebo-controlled randomized, dose ranging study. Ann Intern Med 2008;148:569–577.
104.
Wild RA. Endogenous androgens and cardiovascular risk. Menopause 2007;14:609–610.
105.
Barbach L. For yourself: the fulfillment of female sexuality.New York: Signet, 2000.
106.
Fortney L, Taylor M. Meditation in medical practices: a review of the evidence and practice. Prim Care Clin Office Pract 2010;37:81– 90.
107.
Long CY, Liu CM, Hsu SC, et al. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women. Menopause 2006;13;737–743.
108.
Labrie F, Archer D, Bouchard C, et al. Effect on intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause 2010;16:923–931.
109.
Obermeyer CM. The consequences of female circumcision for health and sexuality: an update on the evidence. Cult Health Sex 2005;7:443–461.
110.
Elnashar A, Abelhady R. The impact of female genital cutting on health of newly married women. Int J Gynaecol Obstet 2007;97:238– 244.
111.
Johnson C, Nour NM. Surgical techniques: defibulation of type III female genital cutting. J Sex Med 2007;4:1544–1547.
112.